Cite
MLA Citation
Philip S. Boonstra et al.. “A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas.” American journal of hematology, vol. 92, no. 12, n.d., pp. 1287–1294. http://access.bl.uk/ark:/81055/vdc_100053601101.0x000042